Drug Reference
Nivolumab / Relatlimab
Combinations of monoclonal antibodies and antibody drug conjugates
Fact box
- Therapeutic class
- Combinations of monoclonal antibodies and antibody drug conjugates
Brand names
Opdualag
Available as
20 ML · Injection
Multi-ingredient product
NivolumabRelatlimab
This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.
Current FDA labels (DailyMed)
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.